ABSTRACT Although electroconvulsive therapy (ECT) is widely used to treat a number of psychiatric disorders, many physicians are still unfamiliar with the procedure, its indications, and its contraindications.This article is an internist’s guide to ECT, with particular focus on how commonly prescribed medications and medical conditions affect ECT. Electroconvulsive therapy (ECT) is indicated for refractory depression, bipolar disorder, and schizophrenia, and there are several case reports highlighting ECT for the treatment of somatic symptom disorder. We present the case of a patient with treatment-refractory somatic symptom disorder treated with six sessions of ECT. Electroconvulsive therapy (ECT) has demonstrated to be highly effective and safe, even life saving for many psychiatric disorders such as major depression, bipolar disorder and schizophrenia. Abstract Despite many predictions that electroconvulsive therapy (ECT) would be replaced by pharmacotherapy, ECT has remained an invaluable adjunct in the management of severe psychiatric disease. Both pharmacotherapy and ECT continue to be used extensively, and will frequently be administered concurrently. The majority of patients requiring ECT will need anaesthesia; therefore, interactions my son (34) took 90 gabapentin (100mg) pills in a two day period. What are the side effects of this as he is also undergoing ECT treatment 3 days a week and he took that many pills before undergoing his 3rd treatment. The British Association for Psychopharmacology developed an evidence-based consensus guideline on the management of catatonia. A group of international experts from a wide range of disciplines was assembled. Evidence was gathered from existing Objectives To review the literature on the concurrent use of electroconvulsive therapy (ECT) and anticonvulsant drugs (AC) and to provide recommendations to guide clinical practice. Methods A MEDLINE search (1985-2006) was performed, using the terms "electroconvulsive therapy," "anticonvulsants," "epilepsy," "carbamazepine," "gabapentin," "lamotrigine," "topiramate," and "valproate Gabapentin is 1 of many antiseizure medications available for the treatment of epilepsy in adults; however, there are potential risks associated with its use. Therefore, it is important to determine the place of therapy of gabapentin in the treatment of epilepsy. treated successfully with gabapentin. Additionally, gabapentin reduced the patient’s anxiety increased subjective quality of sleep, and hence removed barriers to adheren Gabapentin has been used for improvement of insomnia as well as neuropathy4. Presentation of Case: A 56-year old Caucasian male was diagnosed using DSM-IV clinical Electroconvulsive therapy (ECT) depends on the seizure threshold, so you don’t want to throw that off before starting it. Anticonvulsants and benzodiazepines are concerning, as are antidepressants. Although bupropion has a notorious risk for seizures, a recent meta-analysis of all antidepressants found buproprion’s risk was about average with the newer Electroconvulsive therapy (ECT) is an effective treatment for severe psychiatric disorders. Patients referred to ECT are often taking multiple medications, many of which can potentially affect the safety and efficacy of their course of ECT. This review evaluates the impact of a variety of psychotropic medications often used in conjunction with ECT and examines strategies to optimize their Medication management during electroconvulsant therapy Monica Zolezzi Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Doha, Qatar Abstract: Electroconvulsive therapy (ECT) has demonstrated to be highly effective and safe, even life saving for many psychiatric disorders such as major depression, bipolar disorder and schizophrenia. Most patients who require ECT are also on Gabapentin appears to be a promising adjunct during ECT to manage anxiety and myalgia as it did not interfere with seizure duration or clinical effect on depression. Aim: The goal was to determine if use of gabapentin could assist with management of myalgia and anxiety in a patient treated with Electroconvulsive therapy (ECT) for depression, without interfering with seizure activity during ECT Should we continue or stop medications during ECT? This article was first published on February 4, 2023. It was last reviewed/ updated on February 7, 2023. Question from a Member: If a patient is on gabapentin and clonazepam, would they have to taper off of these to be able to start ECT? It is common, indeed usual in many countries including the UK, for patients receiving electroconvulsive therapy (ECT) to continue taking medication for their psychiatric disorder, and in many cases they are also being treated for one or more physical illnesses. This chapter reviews the evidence for interactions between concomitantly taken drugs and ECT, concentrating on safety issues and their The literature that is currently available indicates that ECT can be safely and effectively administered to patients treated with various AC. There is, however, no evidence to combine the 2 treatment modalities to augment therapeutic efficacy. Electroconvulsive therapy (ECT) has demonstrated to be highly effective and safe, even life saving for many psychiatric disorders such as major depression, bipolar disorder and schizophrenia. Most patients who require ECT are also on concurrent Additionally, gabapentin reduced the patient’s anxiety about ECT, increased subjective quality of sleep, and hence removed barriers to adherence. PDF | On Jan 10, 2015, Stephanie Peglow and others published Use of Gabapentin during ECT for Myalgia and Anxiety: Effects on Seizure Activity | Find, read and cite all the research you need on Abstract Aim: The goal was to determine if use of gabapentin could assist with management of myalgia and anxiety in a patient treated with Electroconvulsive therapy (ECT) for depression, without interfering with seizure activity during ECT.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() |